Literature DB >> 10028921

Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid.

K Xu1, A T Malouf, A Messing, J Silver.   

Abstract

Upregulation of the glial fibrillary acidic protein (GFAP) in astrocytes is a hallmark of the phenomenon known as reactive gliosis and, yet, the function of GFAP in this process is largely unknown. Our previous studies have shown that mature astrocytes react vigorously to substrate bound beta-amyloid protein (BAP) in a variety of ways (i.e., increased GFAP, enhanced motility, unusual aggregation patterns, inhibitory ECM production). In order to uncover which, if any, of these phenomena are causally related to the function of GFAP, primary cortical astrocytes from transgenic mice lacking GFAP were cultured on BAP substrates at low or high density and at various lengths of time following in vitro maturation. Differences between mutant and control cells became progressively more obvious when cells were matured in vitro for two weeks or longer and especially in cultures that were at high density. Mature control astrocytes show a dramatic response to BAP by aggregating into a meshwork of rope-like structures that completely bridge over the peptide surface. In marked contrast, mature GFAP-null astrocytes initiate the response much more slowly and had a much reduced ability to aggregate tightly. Furthermore, we prepared hippocampal slice cultures from GFAP-/- and GFAP+/+ mice and compared their astrocytic responses to injected BAP. GFAP-/- astrocytes of hippocampal slice cultures failed to form a barrier-like structure around the edge of the BAP deposit as did GFAP+/+ astrocytes. Our data suggest that GFAP may be essential for mature astrocytes to constrain certain types of highly inflammatory lesions in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028921     DOI: 10.1002/(sici)1098-1136(19990215)25:4<390::aid-glia8>3.0.co;2-7

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

Review 1.  Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.

Authors:  Jerry Silver; Martin E Schwab; Phillip G Popovich
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-04       Impact factor: 10.005

Review 2.  Role of GFAP in CNS injuries.

Authors:  Michael Brenner
Journal:  Neurosci Lett       Date:  2014-02-06       Impact factor: 3.046

3.  AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors.

Authors:  Brian Zingg; Xiao-Lin Chou; Zheng-Gang Zhang; Lukas Mesik; Feixue Liang; Huizhong Whit Tao; Li I Zhang
Journal:  Neuron       Date:  2016-12-15       Impact factor: 17.173

Review 4.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

5.  Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.

Authors:  Grace M Lloyd; Zachary A Sorrentino; Stephan Quintin; Kimberly-Marie M Gorion; Brach M Bell; Giavanna Paterno; Brooke Long; Stefan Prokop; Benoit I Giasson
Journal:  Acta Neuropathol       Date:  2022-04-30       Impact factor: 15.887

Review 6.  "Targeting astrocytes in CNS injury and disease: A translational research approach".

Authors:  Angela R Filous; Jerry Silver
Journal:  Prog Neurobiol       Date:  2016-03-26       Impact factor: 11.685

7.  Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex.

Authors:  Anthony P Nicholas
Journal:  Neurosci Lett       Date:  2013-05-03       Impact factor: 3.046

8.  Abeta mediated diminution of MTT reduction--an artefact of single cell culture?

Authors:  Raik Rönicke; Anja Klemm; Jessica Meinhardt; Ulrich H Schröder; Marcus Fändrich; Klaus G Reymann
Journal:  PLoS One       Date:  2008-09-18       Impact factor: 3.240

Review 9.  Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.

Authors:  Tamar Smit; Natasja A C Deshayes; David R Borchelt; Willem Kamphuis; Jinte Middeldorp; Elly M Hol
Journal:  Glia       Date:  2021-02-25       Impact factor: 7.452

10.  GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease.

Authors:  Willem Kamphuis; Carlyn Mamber; Martina Moeton; Lieneke Kooijman; Jacqueline A Sluijs; Anne H P Jansen; Monique Verveer; Lody R de Groot; Vanessa D Smith; Sindhoo Rangarajan; José J Rodríguez; Marie Orre; Elly M Hol
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.